Digital breast tomosynthesis (DBT) is a promising new technology that acquires 3-D breast images. The individual images are presented as thin, high-resolution slices, which can be displayed individually or in a dynamic cine mode. Preliminary studies in a clinical setting have demonstrated that this new technology has the potential to improve not only the breast cancer detection but also to reduce…
It’s been around for decades, re-emerged in the ’90s and, today, experts see a bright future for tomosynthesis technology. Thus its progress and future developments, plus specialist uses (e.g. breast) will be a particular feature at the Radiological Society of North America scientific assembly and annual meeting in Chicago this year.
Women could be undergoing unnecessary breast surgery as a result of having magnetic resonance imaging, says an expert on bmj.com. In the last decade, says Malcolm Kell, Consultant Surgeon and Senior Lecturer at the Eccles Breast Screening Unit at University College Dublin, MRI or magnetic resonance mammography has become the most favoured type of investigation for high risk patients when combined…
Digital breast tomosynthesis (DBT) is a promising new technology that acquires 3-dimensional images of the breast. The individual images are presented as thin high-resolution slices that can be displayed individually or in a dynamic cine mode. Preliminary studies in a clinical setting have demonstrated that this new technology has the potential to improve not only the detection of breast cancers…
A study looking at breast cancer patients in England compared to those in Norway and Sweden has highlighted the importance of early detection. The three-country comparison reveals that every year almost 1,000 more lives could be saved in England alone.
Standard mammography is the most relevant diagnostic tool to address breast cancer: It shows excellent image quality, a smooth workflow, high connectivity and a very good clinical outcome in terms of sensitivity and specificity. However, there are certain shortcomings to it, especially in dense breast tissue.
Invited by Dr Mahdi Rezai, medical director of the breast centre at Luisen Hospital in Düsseldorf, Germany, and founder of the European Academy of Senology, some 1,400 international specialists attended the 8th Düsseldorf Breast Cancer Conference this June where leading experts evaluated new imaging methods.
During his Honorary Lecture at the 8th Düsseldorf Breast Cancer Conference in Germany world renowned surgeon and oncologist Prof. Veronesi reflected about the prevention and treatment of breast cancer.
White nights in St Petersburg draw in not only romantics, but June in this beautiful city also sees thousands of delegates arrive to attend the many scientific conferences and congresses. Among oncologists, the ‘white nights’ period means another annual scientific conference organised by the NN Petrov Research Institute of Oncology. For its continuing focus on breast cancer, the halls are…
The Italian firm Internazionale Medico Scientifica (IMS) produces highly innovative mammography units under the brand name Giotto. More than 3,500 Giotto systems are now in use in 38 countries, mostly in Europe, America, China and the Far East. Reason enough for European Hospital to visit IMS in Pontecchio Marconi, Bologna.
Innovative technologies such as elastography, shearwave and 3-D have been cause for euphoria in today’s ultrasound world. The most recent development in breast imaging also has the potential to revolutionise this field, because the Automated Volume Breast Scanner (ABVS) is allowing user-independent and reproducible image acquisition for the first time.
Standard mammography is the most relevant diagnostic tool to address breast cancer: It shows excellent image quality, a smooth workflow, high connectivity and a very good clinical outcome in terms of sensitivity and specificity. However, there are certain shortcomings to it, especially in dense breast tissue. Over the last 12 years, technical and clinical research is done with contrast-enhanced…
Italian surgeon and oncologist Prof. Dr. Umberto Veronesi, Founder and Scientific Director of the European Institute of Oncology in Milan and former National Health Minister (2000 – 2001), is considered to be one of the biggest authorities on breast cancer research of our time. Many breakthrough changings in cancer medicine sustainably go back on his researches, which once earned him also a…
The Swedish IT and medical-technology company Sectra has been awarded a contract to install four MicroDose Mammography units for use in Victoria. The Sectra MicroDose units offer improved or identical image quality at a lower radiation dose than other solutions in the market.
Hologic announced that the Hologic Selenia® digital mammography system with a tungsten tube has received “Mammographic Type Test” certification by the European Reference Organization (EUREF) Council for Quality Assured Breast Screening and Diagnostic Services. The Hologic system is the first mammography system of any type to receive this certification.
The German Senology Society has campaigned for women’s breast health for 30 years. Founded in 1980 on the then very novel concept of organ-related, interdisciplinary, scientific cooperation, today a large percentage of the society’s 1,800 members are gynaecologists, radiologists, surgeons and internists.
Siemens Healthcare was presenting its latest solutions for the early detection and treatment of breast cancer at the German Radiology Congress in Berlin. These Breast Care Solutions include a variety of imaging procedures, such as ultrasound, mammography, and magnetic resonance imaging (MRI), supplemented by IT and laboratory diagnostic solutions. Siemens places special focus on the third…
The overall success of MRI in diagnosing breast cancer and the exploding demand for breast MRI, in particular, have caused a scanner shortage in much of Europe. Dr Jean-Pierre Pruvo, Chairman of the French Society of Radiology, recently raised the alarm: ‘We have hundreds of thousands of women in France at risk for breast cancer, yet we do not have the means to provide a breast examination by…
The limitations of mammography are well documented, yet it is still the gold standard in breast cancer detection - particularly due to the positive cost-benefit ratio. Due to prohibitive costs, MRI exams are performed only in well-defined cases. The HIGHREX project (www.highrex.eu) aims to evaluate Single Shot Spectral Imaging (SSSI) technology for use in mamma diagnostics.
Performing pre-operative breast MRI in all women with invasive lobular carcinoma (ILC) can reduce the need for re-excision, according to a study conducted through two major cancer centres - the Radboud University Nijmegen Medical Centre and the Netherlands Cancer Hospital/Antoni van Leeuwenhoek Hospital.
Within Germany’s mammography screening programme, more than 10 million women, aged between 50 and 69 years, are entitled to a breast examination. It’s taken just over a year for all 94 of the country’s screening units to open their doors to meet this demand comprehensively.
An international survey of women with metastatic breast cancer conducted to evaluate their perceptions of quality of life and what additional medical information and support was needed to help them uncovered an unexpected finding. At a time when patients with incurable cancer are needed to participate in clinical trials, the majority of these women were never advised about any breast cancer…
At ECR 2010 in Vienna, Sectra focus on solutions for increased productivity. Sectra RIS/PACS is a performance solution for wide area radiology. Built on the latest Sectra RapidConnectTM technology, it allows radiologists to work from any location that offers reasonable Internet access and to share images and information between multiple locations with ease.
Digital mammograms deliver an average of 22% less radiation than film mammograms, according to a study partially funded by the National Cancer Institute and published in the American Journal of Roentgenology, Reuters reports. For the study, researchers analyzed the results of the 2005 Digital Mammographic Imaging Screening Trial involving 49,528 women. That trial found that digital mammograms…
New research on deaths from cancer in Europe concludes that the key priority for continuing to reduce mortality is cutting tobacco smoking. The study shows that, while deaths for men from lung cancer in the EU have declined overall, by 17 % from 1995 to 2004, they rose by 27% for women over the same period. It also reveals other significant differences in the mortality between different EU…